Fera introduces Sulfacetamide Ointment for conjunctivitis

NewsGuard 100/100 Score

Fera Pharmaceuticals is pleased to announce the launch of Sulfacetamide Sodium Ophthalmic Ointment USP, 10%.

Indicated for superficial ocular infections, including conjunctivitis, Sulfacetamide, in ointment form, will be an important addition to physicians' treatment armamentarium.

David Cobb, VP of Ophthalmics at Fera says "Fera recognized the need to bring Sulfacetamide Ointment to the market. While doctors have access to Sulfacetamide eye drops, ointments have the advantage of maintaining eye contact time longer, particularly in pediatric patients whose tears may inadvertently wash drops out from the eye. In addition, Sulfacetamide ointment is an important treatment adjunct to the solution, especially at nighttime."

"Bringing Sulfacetamide Sodium Ophthalmic Ointment to market is very much in keeping with Fera's vision" says Frank DellaFera, President. "There were other such products available years ago, but their manufacturers decided to discontinue them. We listened to the marketplace and brought it back!"

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab